Cara Resuming Phase III Trial In Post-Op Pain After Clinical Hold Lifts

Novel analgesic can resume a Phase III study in post-surgical pain after findings of hypernatremia in a now-ended, high-dose cohort of the selective kappa opioid receptor agonist.